Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MP4OX in Trauma with Lactic Acidosis
NCT01973504Phase 2Withdrawn
- Sponsor
- Sangart
- Start
- Dec 2013
- Primary completion
- Dec 2015
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 11
01
Overview
A Phase 2 trial of Hemospan in hemorrhagic shock, lactic acidosis, sponsored by Sangart. Planned start Dec 2013; status: withdrawn.
02
Drugs
Hemospan
03
Conditions
hemorrhagic shocklactic acidosis
Beyond the preview
Go deeper on NCT01973504.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01973504.